Kaliappanadar Nellaiappan

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 2

Top Topics

Tandem Mass Spectrometry

Top Venues

Antibodies (Basel, Switzerland)

Pharmaceutical research

CuriRx (United States)

CuriRx (United States) (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CuriRx (United States) Nov 01 2011

United States

Director

Education History

CuriRx (United States) Oct 01 2011

United States

PHD :: R&D

Publications

Vaneet K Sharma, Bijay Misra, Kevin T McManus, Sreenivas Avula, Kaliappanadar Nellaiappan, Marina Caskey, Jill Horowitz, Michel C Nussenzweig, Michael S Seaman, Indu Javeri, Antu K Dey
Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration. Antibodies (Basel, Switzerland) 9 (3) (2020)
Indu Javeri, Kaliappanadar Nellaiappan, Charles McNemar, Kirill Yakovlevsky, Amina Soukrati, Phanindra Velisetty, Bijay Misra
Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution. Pharmaceutical research 35 (9) (2018)